{"name":"OncoResponse, Inc.","slug":"oncoresponse-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNOGVHTVIzM1pxcHZIVHg3b1dzTE9aMnNDbUFUOWJ0ZmZ0c1Q4Y1EtYXVGMGVXdnlKVk5uN2VObEtUcHZBUzk2OGgteGdaWkctajNrRDgwWUItWkVBb2R0QmZOWTVHd2pLdmZVM0h4X2N2TGpncGZqdzhwMDVZRzRuY3FCUkg1SjcxcDZrNkdPTXRWRC1EVlVXaUstbXYzbWh3MmtINGtn0gGrAUFVX3lxTFBTeEZIcUdFMkFkTG1ZMFRaV2kxbnN3ZzJoVmJDMGZBNjA5bXNseDFSYlljZzFBU3l4d1E2NzFXaFdiZW94akVZYnhBX1NuaVhYWG1RSUdFbG1TZmNndUhxb3loM2tyYkc1eGZfUk1qTGxHVldUcEFPUml1R1dJaDltUXczdVJJRkpoWHlicVdxR19XRVBMUndCbjZrUGlSajczZ2ZXcklTNnVVcw?oc=5","date":"2025-02-24","type":"pipeline","source":"Pulse 2.0","summary":"Perceive Pharma: $15 Million (Series A) Raised For Advancing Ophthalmic Neuroprotection - Pulse 2.0","headline":"Perceive Pharma: $15 Million (Series A) Raised For Advancing Ophthalmic Neuroprotection - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOdVlhOFhDYnpBRGh4WlhFWG93ZHdmak5FZDVRVC1qWER1YlFhbnQ5TThBM0Y5ZjJaaExucGI2LVNsSmRUMDQ3cVBHT211N1JHVXNBRklDUTR1VjdITWkxSTA5OXNTMkZ2S3hnVDBMNHJYamp2Ri1UcHhBRlBLUWNxLXFMeHRlXzFpOXpkRzF4NlZWYlBGS0xqaGlHSlMzMkRFcG1tRjd4aU5sOE5TUWJvdklNd0F5YmZIMU91Tng5X0F3UlJESVI1M0tDaUFid2c1MjlhMlFiTHNGaUViTkN3b01pM2J4cndGY0NueG9VTTl0bGtmWF9KcEpZOVlodHZQWE5FbW1aNDBzTTNZTVNWTWpWZjhVM00zcHZIUV9sTQ?oc=5","date":"2025-01-14","type":"trial","source":"prnewswire.com","summary":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight - prnewswire.com","headline":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Develop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1ULVVxMlozN2g1em9LcWxpRWJRSGc0Mm9YeEEzOW1SV05WNnowV1FJZHJmRTU5Vm1OWTFjZVRSNWlza3llSjI2SDNkdDRSdS1JRE1jZHJicmkwek5NSGFvSXZUR3pSTzhXUU9WbEpfSEdKTDY2cEJsOVRIQ2N6N0U?oc=5","date":"2023-07-11","type":"earnings","source":"InnovationMap","summary":"Amid international VC decline, here's what Houston startups received investment, grant funding last quarter - InnovationMap","headline":"Amid international VC decline, here's what Houston startups received investment, grant funding last quarter","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQMHRsUHp5MHhRa1Z2SjFvb0kwR3g2YjBQTlNjLWRDMk9COHgyZTY3elFyV0R2bnphTy03M0k1ZHo5c0VtdFh1UmRxUzlFeC1XZk5IM3BYRFVtMzl0QzZyMUNEZ2pPeUlmVmRtUDdiRk1sdkZTMmpULWZwalpBZVNjak9nWFpYZW1FcEZKa1JR?oc=5","date":"2023-05-17","type":"pipeline","source":"ASCO Daily News","summary":"Drug Development in Gastric Cancer: Are We at an Inflection Point? - ASCO Daily News","headline":"Drug Development in Gastric Cancer: Are We at an Inflection Point?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPRHdnbllmUFZOQkNJSzFjQlcxcEFQVW9ELTBMcFZERVZ1MEtWQWFBcHlLYVBoTFVrMXo3ZE5WNkdBbjdUdW1YbGttcEVEX0FNWHlDU19DSkNEWUhxbVNhOU9sWkFSTDBRbXFTNXlBWVYyVUpRMXZEdGszM09GU2s2WUpUdVZhZ0JLdjhyOWtEQ0liWmg1Q1g5NkhhczJLTnZGa293M2N1cGM4b3llR2VMMGxLZkM4bThSc29UMV8wQlpnaV9FYXV2MlJKMUxKZ0drOEM5bzk0MzI3dV96bEZ3?oc=5","date":"2022-02-15","type":"pipeline","source":"businesswire.com","summary":"Oxford Finance Announces the Closing of a $50 Million Credit Facility With OncoResponse - businesswire.com","headline":"Oxford Finance Announces the Closing of a $50 Million Credit Facility With OncoResponse","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}